Histogram
Visit (Number) vs PM Systolic Blood Presure 2nd Measurement
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
| Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
| Diagnostic Visit (DX) | 1,232 | 123.4 | ± 19.8 | 124.0 | -2.0 | 188.0 | 284 | 1,516 |
| CPAP Titration Visit (CPAP) | 1,056 | 122.3 | ± 22.1 | 124.0 | -1.0 | 190.0 | 460 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 122.3 | ± 20.5 | 124.0 | -1.0 | 186.0 | 637 | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 14.8 | ± 42.3 | -2.0 | -2.0 | 172.0 | 683 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 120.3 | ± 24.4 | 122.0 | -3.0 | 176.0 | 665 | 1,516 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 123.4 | ± 19.8 | 124.0 | -2.0 | 188.0 | 284 | 1,516 |
| Male | 788 | 124.6 | ± 18.6 | 124.0 | -1.0 | 188.0 | 170 | 958 |
| Female | 444 | 121.4 | ± 21.7 | 122.0 | -2.0 | 174.0 | 114 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 122.3 | ± 22.1 | 124.0 | -1.0 | 190.0 | 460 | 1,516 |
| Male | 693 | 123.6 | ± 20.5 | 125.0 | -1.0 | 190.0 | 265 | 958 |
| Female | 363 | 119.8 | ± 24.7 | 122.0 | -1.0 | 166.0 | 195 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 122.3 | ± 20.5 | 124.0 | -1.0 | 186.0 | 637 | 1,516 |
| Male | 572 | 122.8 | ± 20.7 | 124.0 | -1.0 | 186.0 | 386 | 958 |
| Female | 307 | 121.4 | ± 20.1 | 122.0 | -1.0 | 168.0 | 251 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 14.8 | ± 42.3 | -2.0 | -2.0 | 172.0 | 683 | 1,516 |
| Male | 541 | 14.8 | ± 42.4 | -2.0 | -2.0 | 172.0 | 417 | 958 |
| Female | 292 | 15.0 | ± 42.2 | -2.0 | -2.0 | 154.0 | 266 | 558 |
Gender vs PM Systolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 120.3 | ± 24.4 | 122.0 | -3.0 | 176.0 | 665 | 1,516 |
| Male | 552 | 121.3 | ± 23.8 | 123.0 | -2.0 | 176.0 | 406 | 958 |
| Female | 299 | 118.6 | ± 25.6 | 122.0 | -3.0 | 170.0 | 259 | 558 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 123.4 | ± 19.8 | 124.0 | -2.0 | 188.0 | 284 | 1,516 |
| Native American | 20 | 125.5 | ± 18.7 | 120.0 | 98.0 | 184.0 | 8 | 28 |
| Asian | 74 | 120.0 | ± 19.7 | 120.0 | -1.0 | 152.0 | 15 | 89 |
| Black | 120 | 123.8 | ± 20.9 | 123.0 | -1.0 | 174.0 | 52 | 172 |
| Hispanic | 84 | 125.2 | ± 12.2 | 124.0 | 102.0 | 164.0 | 32 | 116 |
| White | 926 | 123.5 | ± 19.9 | 124.0 | -2.0 | 188.0 | 176 | 1,102 |
| Other | 8 | 114.5 | ± 50.3 | 123.0 | -1.0 | 166.0 | 1 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 122.3 | ± 22.1 | 124.0 | -1.0 | 190.0 | 460 | 1,516 |
| Native American | 16 | 133.2 | ± 22.1 | 128.0 | 100.0 | 190.0 | 12 | 28 |
| Asian | 58 | 119.3 | ± 19.3 | 120.0 | -1.0 | 152.0 | 31 | 89 |
| Black | 96 | 124.6 | ± 22.3 | 126.0 | -1.0 | 170.0 | 76 | 172 |
| Hispanic | 73 | 124.5 | ± 10.8 | 122.0 | 100.0 | 150.0 | 43 | 116 |
| White | 808 | 121.7 | ± 23.0 | 124.0 | -1.0 | 182.0 | 294 | 1,102 |
| Other | 5 | 128.6 | ± 22.8 | 120.0 | 110.0 | 168.0 | 4 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 122.3 | ± 20.5 | 124.0 | -1.0 | 186.0 | 637 | 1,516 |
| Native American | 13 | 122.1 | ± 41.3 | 132.0 | -1.0 | 170.0 | 15 | 28 |
| Asian | 49 | 120.7 | ± 10.8 | 120.0 | 86.0 | 138.0 | 40 | 89 |
| Black | 77 | 127.1 | ± 12.3 | 125.0 | 102.0 | 180.0 | 95 | 172 |
| Hispanic | 65 | 121.1 | ± 25.0 | 126.0 | -1.0 | 158.0 | 51 | 116 |
| White | 672 | 121.9 | ± 20.7 | 122.0 | -1.0 | 186.0 | 430 | 1,102 |
| Other | 3 | 137.3 | ± 19.7 | 128.0 | 124.0 | 160.0 | 6 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 14.8 | ± 42.3 | -2.0 | -2.0 | 172.0 | 683 | 1,516 |
| Native American | 10 | 12.5 | ± 45.9 | -2.0 | -2.0 | 143.0 | 18 | 28 |
| Asian | 47 | 13.1 | ± 40.3 | -2.0 | -2.0 | 132.0 | 42 | 89 |
| Black | 73 | 12.4 | ± 41.8 | -2.0 | -2.0 | 172.0 | 99 | 172 |
| Hispanic | 57 | 8.1 | ± 32.8 | -2.0 | -2.0 | 122.0 | 59 | 116 |
| White | 643 | 15.9 | ± 43.3 | -2.0 | -2.0 | 154.0 | 459 | 1,102 |
| Other | 3 | -2.0 | ± 0.0 | -2.0 | -2.0 | -2.0 | 6 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 120.3 | ± 24.4 | 122.0 | -3.0 | 176.0 | 665 | 1,516 |
| Native American | 13 | 94.0 | ± 55.2 | 118.0 | -1.0 | 140.0 | 15 | 28 |
| Asian | 50 | 117.9 | ± 20.1 | 120.0 | -1.0 | 146.0 | 39 | 89 |
| Black | 75 | 120.9 | ± 32.0 | 126.0 | -1.0 | 176.0 | 97 | 172 |
| Hispanic | 61 | 118.0 | ± 24.7 | 122.0 | -1.0 | 158.0 | 55 | 116 |
| White | 649 | 121.2 | ± 22.5 | 122.0 | -3.0 | 170.0 | 453 | 1,102 |
| Other | 3 | 131.3 | ± 27.2 | 122.0 | 110.0 | 162.0 | 6 | 9 |